Stock info Scynexis Inc | Filter  Basic-Info

Scynexis Inc

The past year was a profitable year for the Scynexis Inc investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 52 percent. Over the period 2011-2016 the stock lost a modest 0 percent. Scynexis Inc's revenues between 2011 and 2015 were quite unstable and moved between 16,84 million dollars and 0,26 million dollars.

Scynexis Inc primarily operates in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent over the last 10 years. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The American company didn't pay out any dividends (in the past 5 years).

Scynexis Inc financed with lots of debt

At the end of 2015 the pharmaceutical company's balance sheet was worth 49,27 million dollars. At the end of 2015 the total debt positon equaled 7,32 million dollars. This is around 14,86 percent of the total balance sheet. The American company's price/earnings-ratio was -4. So the market valued the stock at -4 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the pharmaceutical company equaled around 75,41 million dollars. At the end of 2015 the American company had around 12,16 million stocks listed on the stock exchange(s).

All Scynexis Inc's annual reports can be found here. More information about Scynexis Inc can be found it's website. .